Health execs must brace for autoimmune drug changes

Share it

 

industry-trends-article-4

Autoimmune specialty drugs now account for about $1 of every $10 of combined drug expense through the medical and pharmacy benefits in a commercially insured population, according to research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus, on October 4, in National Harbor, Maryland.

Continue Reading Article

See more news